Jan Komorowski

ORCID: 0000-0002-0766-8789
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genomics and Chromatin Dynamics
  • Rough Sets and Fuzzy Logic
  • Gene expression and cancer classification
  • Bioinformatics and Genomic Networks
  • Cancer Genomics and Diagnostics
  • Data Mining Algorithms and Applications
  • RNA modifications and cancer
  • Growth Hormone and Insulin-like Growth Factors
  • Epigenetics and DNA Methylation
  • Machine Learning in Bioinformatics
  • RNA Research and Splicing
  • Logic, programming, and type systems
  • RNA and protein synthesis mechanisms
  • Pituitary Gland Disorders and Treatments
  • Cancer, Hypoxia, and Metabolism
  • Logic, Reasoning, and Knowledge
  • Computational Drug Discovery Methods
  • Genomics and Phylogenetic Studies
  • Angiogenesis and VEGF in Cancer
  • Cancer-related molecular mechanisms research
  • Biomedical Text Mining and Ontologies
  • Thyroid Disorders and Treatments
  • Semantic Web and Ontologies
  • HIV Research and Treatment
  • Protease and Inhibitor Mechanisms

Institute of Computer Science
2015-2024

Uppsala University
2014-2023

Linnaeus University
2004-2023

Science for Life Laboratory
2013-2023

Polish Academy of Sciences
2014-2023

Swedish Collegium for Advanced Study
2021-2022

Medical University of Lodz
2011-2021

Umeå University
2008-2021

Oregon National Primate Research Center
2021

Karolinska Institutet
2021

Esther Rheinbay Morten Muhlig Nielsen Federico Abascal Jeremiah A. Wala Ofer Shapira and 95 more Grace Tiao Henrik Hornshøj Julian M. Hess Randi Istrup Juul Ziao Lin Lars Feuerbach Radhakrishnan Sabarinathan Tobias Madsen Jaegil Kim Loris Mularoni Shimin Shuai Andrés Lanzós Carl Herrmann Yosef E. Maruvka Ciyue Shen Samirkumar B. Amin Pratiti Bandopadhayay Johanna Bertl Keith A. Boroevich John Busanovich Joana Carlevaro-Fita Dimple Chakravarty Calvin Wing Yiu Chan David Craft Priyanka Dhingra Klev Diamanti Nuno A. Fonseca Abel González-Pérez Qianyun Guo Mark P. Hamilton Nicholas J. Haradhvala Hong Chen Keren Isaev Todd A. Johnson Malene Juul André Kahles Abdullah Kahraman Young-Wook Kim Jan Komorowski Kiran Kumar Sushant Kumar Donghoon Lee Kjong-Van Lehmann Yilong Li Eric Minwei Liu Lucas Lochovsky Keunchil Park Oriol Pich Nicola D. Roberts Gordon Saksena Steven E. Schumacher Nikos Sidiropoulos Lina Sieverling Nasa Sinnott-Armstrong Chip Stewart David Tamborero José M. C. Tubío Husen M. Umer Liis Uusküla-Reimand Claes Wadelius Lina Wadi Xiaotong Yao Cheng‐Zhong Zhang Jing Zhang James E. Haber Asger Hobolth Marcin Imieliński Manolis Kellis Michael S. Lawrence Christian von Mering Hidewaki Nakagawa Benjamin J. Raphael Mark A. Rubin Chris Sander Lincoln D. Stein Joshua M. Stuart Tatsuhiko Tsunoda David A. Wheeler Rory Johnson Jüri Reimand Mark Gerstein Ekta Khurana Peter J. Campbell Núria López-Bigas Federico Abascal Samirkumar B. Amin Gary D. Bader Pratiti Bandopadhayay Jonathan Barenboim Rameen Beroukhim Johanna Bertl Keith A. Boroevich Søren Brunak Peter J. Campbell Joana Carlevaro-Fita

The discovery of drivers cancer has traditionally focused on protein-coding genes

10.1038/s41586-020-1965-x article EN cc-by Nature 2020-02-05

The genomes of higher organisms are packaged in nucleosomes with functional histone modifications. Until now, genome-wide nucleosome and modification studies have focused on transcription start sites (TSSs) where RNA polymerase II (RNAPII) occupied genes well positioned modifications that characteristic expression status. Using public data, we here show there is a nucleosome-positioning signal internal human exons this positioning independent expression. We observed similarly strong...

10.1101/gr.092353.109 article EN cc-by-nc Genome Research 2009-08-17
Joana Carlevaro-Fita Andrés Lanzós Lars Feuerbach Chen Hong David Mas-Ponte and 95 more Jakob Skou Pedersen Federico Abascal Samirkumar B. Amin Gary D. Bader Jonathan Barenboim Rameen Beroukhim Johanna Bertl Keith A. Boroevich Søren Brunak Peter J. Campbell Joana Carlevaro-Fita Dimple Chakravarty Calvin Wing Yiu Chan Ken Chen Jung Kyoon Choi Jordi Deu-Pons Priyanka Dhingra Klev Diamanti Lars Feuerbach J. Lynn Fink Nuno A. Fonseca Joan Frigola Carlo Gambacorti‐Passerini Dale W. Garsed Mark Gerstein Gad Getz Abel González-Pérez Qianyun Guo Marta Gut David Haan Mark P. Hamilton Nicholas J. Haradhvala Arif Harmanci Mohamed Helmy Carl Herrmann Julian M. Hess Asger Hobolth Ermin Hodzic Chen Hong Henrik Hornshøj Keren Isaev José M. G. Izarzugaza Rory Johnson Todd A. Johnson Malene Juul Randi Istrup Juul André Kahles Abdullah Kahraman Manolis Kellis Ekta Khurana Seungchan Kim Jong K. Kim Young-Wook Kim Jan Komorowski Jan O. Korbel Sushant Kumar Andrés Lanzós Erik G. Larsson Michael S. Lawrence Dong-Hoon Lee Kjong-Van Lehmann Shantao Li Xiaotong Li Ziao Lin Eric Minwei Liu Lucas Lochovsky Shaoke Lou Tobias Madsen Kathleen Marchal Iñigo Martincorena Alexander Martínez-Fundichely Yosef E. Maruvka Patrick D. McGillivray Matthew Meyerson Ferran Muiños Loris Mularoni Hidewaki Nakagawa Morten Muhlig Nielsen Marta Paczkowska Keunchil Park Kiejung Park Jakob Skou Pedersen Oriol Pich Tirso Pons Sergio Pulido-Tamayo Benjamin J. Raphael Jüri Reimand Iker Reyes-Salazar Matthew A. Reyna Esther Rheinbay Mark A. Rubin Carlota Rubio-Pérez Radhakrishnan Sabarinathan S. Cenk Sahinalp Gordon Saksena

Abstract Long non-coding RNAs (lncRNAs) are a growing focus of cancer genomics studies, creating the need for resource lncRNAs with validated roles. Furthermore, it remains debated whether mutated can drive tumorigenesis, and such functions could be conserved during evolution. Here, as part ICGC/TCGA Pan-Cancer Analysis Whole Genomes (PCAWG) Consortium, we introduce Cancer LncRNA Census (CLC), compilation 122 GENCODE causal roles in phenotypes. In contrast to existing databases, CLC requires...

10.1038/s42003-019-0741-7 article EN cc-by Communications Biology 2020-02-05
Marta Paczkowska Jonathan Barenboim Nardnisa Sintupisut Natalie S. Fox Helen Zhu and 95 more Diala Abd-Rabbo Miles W. Mee Paul C. Boutros Federico Abascal Samirkumar B. Amin Gary D. Bader Rameen Beroukhim Johanna Bertl Keith A. Boroevich Søren Brunak Peter J. Campbell Joana Carlevaro-Fita Dimple Chakravarty Calvin Wing Yiu Chan Ken Chen Jung Kyoon Choi Jordi Deu-Pons Priyanka Dhingra Klev Diamanti Lars Feuerbach J. Lynn Fink Nuno A. Fonseca Joan Frigola Carlo Gambacorti‐Passerini Dale W. Garsed Mark Gerstein Gad Getz Abel González-Pérez Qianyun Guo Marta Gut David Haan Mark Hamilton Nicholas J. Haradhvala Arif Harmanci Mohamed Helmy Carl Herrmann Julian M. Hess Asger Hobolth Ermin Hodzic Chen Hong Henrik Hornshøj Keren Isaev José M. G. Izarzugaza Rory Johnson Todd A. Johnson Malene Juul Randi Istrup Juul André Kahles Abdullah Kahraman Manolis Kellis Ekta Khurana Jaegil Kim Jong K. Kim Young-Wook Kim Jan Komorowski Jan O. Korbel Sushant Kumar Andrés Lanzós Michael S. Lawrence Dong-Hoon Lee Kjong-Van Lehmann Shantao Li Xiaotong Li Ziao Lin Eric Minwei Liu Lucas Lochovsky Shaoke Lou Tobias Madsen Kathleen Marchal Iñigo Martincorena Alexander Martínez-Fundichely Yosef E. Maruvka Patrick D. McGillivray William Meyerson Ferran Muiños Loris Mularoni Hidewaki Nakagawa Morten Muhlig Nielsen Keunchil Park Kiejung Park Jakob Skou Pedersen Oriol Pich Tirso Pons Sergio Pulido-Tamayo Benjamin J. Raphael Iker Reyes-Salazar Matthew A. Reyna Esther Rheinbay Mark A. Rubin Carlota Rubio-Pérez Radhakrishnan Sabarinathan S. Cenk Şahinalp Gordon Saksena Leonidas Salichos Chris Sander

Multi-omics datasets represent distinct aspects of the central dogma molecular biology. Such high-dimensional profiles pose challenges to data interpretation and hypothesis generation. ActivePathways is an integrative method that discovers significantly enriched pathways across multiple using statistical fusion, rationalizes contributing evidence highlights associated genes. As part ICGC/TCGA Pan-Cancer Analysis Whole Genomes (PCAWG) Consortium, which aggregated whole genome sequencing from...

10.1038/s41467-019-13983-9 article EN cc-by Nature Communications 2020-02-05

Abstract Purpose: Patients with metastatic adenocarcinoma of unknown origin are a common clinical problem. Knowledge the primary site is important for their management, but histologically, such tumors appear similar. Better diagnostic markers needed to enable assignment metastases likely sites on pathologic samples. Experimental Design: Expression profiling 27 candidate was done using tissue microarrays and immunohistochemistry. In first (training) round, we studied 352 adenocarcinomas, from...

10.1158/1078-0432.ccr-04-2236 article EN Clinical Cancer Research 2005-05-15

Pre-selection of informative features for supervised classification is a crucial, albeit delicate, task. It desirable that feature selection provides the contribute most to task per se and which should therefore be used by any classifier later produce rules. In this article, conceptually simple but computer-intensive approach proposed. The reliability rests on multiple construction tree many training sets randomly chosen from original sample set, where samples in each set consist only...

10.1093/bioinformatics/btm486 article EN cc-by-nc Bioinformatics 2007-11-28

Two major types of genetic variation are known: single nucleotide polymorphisms (SNPs), and a more recently discovered structural variation, involving changes in copy number (CNVs) kilobase- to megabase-sized chromosomal segments. It is unknown whether CNVs arise somatic cells, but it is, however, generally assumed that normal cells genetically identical. We tested 34 tissue samples from three subjects and, having analyzed for each < or =10(-6) all expected an adult human, we observed at...

10.1002/humu.20815 article EN Human Mutation 2008-06-20

Most neurological diseases are associated with chronic inflammation initiated by the activation of microglia, which produce cytotoxic and inflammatory factors. Signal transducers activators transcription (STATs) potent regulators gene expression but contribution particular STAT to STAT-dependent transcriptional networks underlying brain need be identified. In present study, we investigated genomic distribution Stat binding sites role Stats in lipopolysaccharide (LPS)-activated primary...

10.1007/s00109-013-1090-5 article EN cc-by Journal of Molecular Medicine 2013-10-05

Butyrate is a histone deacetylase inhibitor (HDACi) with anti-neoplastic properties, which theoretically reactivates epigenetically silenced genes by increasing global acetylation. However, recent studies indicate that similar number or even more are down-regulated than up-regulated this drug. We treated hepatocarcinoma HepG2 cells butyrate and characterized the levels of acetylation at DNA-bound histones H3 H4 ChIP-chip along ENCODE regions. In contrast to increases acetylation, many...

10.1101/gr.5540007 article EN cc-by-nc Genome Research 2007-06-01
Matthew A. Reyna David Haan Marta Paczkowska Lieven P. C. Verbeke Miguél Vázquez and 95 more Abdullah Kahraman Sergio Pulido-Tamayo Jonathan Barenboim Lina Wadi Priyanka Dhingra Raunak Shrestha Gad Getz Michael S. Lawrence Jakob Skou Pedersen Mark A. Rubin David A. Wheeler Søren Brunak José M. G. Izarzugaza Ekta Khurana Kathleen Marchal Christian von Mering S. Cenk Şahinalp Alfonso Valencia Federico Abascal Samirkumar B. Amin Gary D. Bader Pratiti Bandopadhayay Rameen Beroukhim Johanna Bertl Keith A. Boroevich John Busanovich Peter J. Campbell Joana Carlevaro-Fita Dimple Chakravarty Calvin Wing Yiu Chan Ken Chen Jung Kyoon Choi Jordi Deu-Pons Klev Diamanti Lars Feuerbach J. Lynn Fink Nuno A. Fonseca Joan Frigola Carlo Gambacorti‐Passerini Dale W. Garsed Mark Gerstein Qianyun Guo Marta Gut Mark P. Hamilton Nicholas J. Haradhvala Arif Harmanci Mohamed Helmy Carl Herrmann Julian M. Hess Asger Hobolth Ermin Hodzic Chen Hong Henrik Hornshøj Keren Isaev Rory Johnson Todd A. Johnson Malene Juul Randi Istrup Juul André Kahles Manolis Kellis Seungchan Kim Jong K. Kim Young-Wook Kim Jan Komorowski Jan O. Korbel Sushant Kumar Andrés Lanzós Erik Larsson Donghoon Lee Kjong-Van Lehmann Shantao Li Xiaotong Li Ziao Lin Eric Minwei Liu Lucas Lochovsky Shaoke Lou Tobias Madsen Iñigo Martincorena Alexander Martínez-Fundichely Yosef E. Maruvka Patrick D. McGillivray William Meyerson Ferran Muiños Loris Mularoni Hidewaki Nakagawa Morten Muhlig Nielsen Keunchil Park Kiejung Park Tirso Pons Iker Reyes-Salazar Esther Rheinbay Carlota Rubio-Pérez Gordon Saksena Leonidas Salichos Chris Sander

Abstract The catalog of cancer driver mutations in protein-coding genes has greatly expanded the past decade. However, non-coding are less well-characterized and only a handful recurrent mutations, most notably TERT promoter have been reported. Here, as part ICGC/TCGA Pan-Cancer Analysis Whole Genomes (PCAWG) Consortium, which aggregated whole genome sequencing data from 2658 across 38 tumor types, we perform multi-faceted pathway network analyses 2583 genomes 27 types compiled by PCAWG...

10.1038/s41467-020-14367-0 article EN cc-by Nature Communications 2020-02-05

An operational semantics of the Prolog programming language is introduced. Meta-IV used to specify semantics. One purpose work provide a specification an implementation interpreter. Another one application this formal description program optimization techniques based on principle partial evaluation.Transformations which account for pruning, forward data structure propagation and opening (which also provides backward propagation) are formally introduced proved preserve meaning programs. The...

10.1145/582153.582181 article EN 1982-01-01

Transcription factors and histone modifications are crucial regulators of gene expression that mutually influence each other. We present the DNA binding profiles upstream stimulatory 1 2 (USF1, USF2) acetylated H3 (H3ac) in a liver cell line for whole human genome using ChIP-chip at resolution 35 base pairs. determined these three proteins bind mostly proximity protein coding genes transcription start sites (TSSs), their bindings positively correlated with levels. Based on spatial functional...

10.1101/gr.6880908 article EN cc-by-nc Genome Research 2008-01-29

Expression of a large number yeast genes is repressed by glucose. The zinc finger protein Mig1 the main effector in glucose repression, but also has two related proteins: Mig2 and Mig3. We have used microarrays to study global gene expression all possible combinations mig1, mig2 mig3 deletion mutants.Mig1 repress largely overlapping set on 2% Genes that are upregulated mig1 double mutant were grouped according contribution Mig2. Most them show partially redundant with being major repressor,...

10.1186/1471-2164-9-601 article EN cc-by BMC Genomics 2008-12-01

Relapse is the leading cause of death adult and pediatric patients with acute myeloid leukemia (AML). Numerous studies have helped to elucidate complex mutational landscape at diagnosis AML, improved risk stratification new therapeutic options. However, multi-whole-genome AML relapse are necessary for further advances. To this end, we performed whole-genome whole-exome sequencing analyses longitudinal diagnosis, relapse, and/or primary resistant specimens from 48 25 AML. We identified...

10.1182/bloodadvances.2020003709 article EN cc-by-nc-nd Blood Advances 2021-02-09

The aim of the present study was to generate hypotheses on involvement uncharacterized genes in biological processes. To this end, supervised learning used analyze microarray-derived time-series gene expression data. Our method objectively evaluated known using cross-validation and provided high-precision Gene Ontology process classifications for 211 213 data set used. In addition, new roles were hypothesized genes. uses knowledge expressed by generates a rule model associating with minimal...

10.1101/gr.1144503 article EN cc-by-nc Genome Research 2003-04-14

Microarray technology enables large-scale inference of the participation genes in biological process from similar expression profiles. Our aim is to induce classificatory models data and knowledge that can automatically associate with novel hypotheses process.We report a systematic supervised learning approach predicting time series gene knowledge. Biological expressed using ontology this associated discriminatory expression-based features form minimal decision rules. The resulting rule...

10.1093/bioinformatics/btg047 article EN Bioinformatics 2003-06-11

Disease-associated SNPs detected in large-scale association studies are frequently located non-coding genomic regions, suggesting that they may be involved transcriptional regulation. Here we describe a new strategy for detecting regulatory (rSNPs), by combining computational and experimental approaches. Whole genome ChIP-chip data USF1 was analyzed using novel motif finding algorithm called BCRANK. 1754 binding sites were identified 140 candidate rSNPs found the predicted sites. For...

10.1093/nar/gkp381 article EN cc-by-nc Nucleic Acids Research 2009-05-18

Gene expression is regulated by combinations of transcription factors, which can be mapped to regulatory elements on a genome-wide scale using ChIP experiments. In previous ChIP-chip study USF1 and USF2 we found evidence also binding GABP, FOXA2 HNF4a within the enriched regions. Here, have applied ChIP-seq for these factors identified 3064 peaks enrichment 7266 18783 HNF4a. Distal with signal was frequently bound FOXA2. GABP were at start sites, whereas 94% 90% located other positions. We...

10.1093/nar/gkp823 article EN cc-by-nc Nucleic Acids Research 2009-10-10
Coming Soon ...